Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong · Delayed Price · Currency is HKD 53.85
+1.40 (2.67%)
May 28, 2026, 10:20 AM HKT
HKG:2315 Market Cap
HKG:2315 has a market cap or net worth of 49.48 billion as of May 27, 2026. Its market cap has increased by 881.75% in one year.
Market Cap
49.48B
Enterprise Value
49.22B
Revenue
1.78B
Ranking
n/a
PE Ratio
64.41
Stock Price
53.85
Market Cap Chart
Since September 1, 2022, HKG:2315's market cap has increased from 10.31B to 49.48B, an increase of 379.78%. That is a compound annual growth rate of 52.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 49.48B | 109.81% |
| Dec 31, 2025 | 23.58B | 594.71% |
| Dec 31, 2024 | 3.39B | -29.05% |
| Dec 29, 2023 | 4.78B | -53.29% |
| Dec 30, 2022 | 10.24B | -0.67% |
| Sep 1, 2022 | 10.31B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sichuan Kelun-Biotech Biopharmaceutical | 107.92B |
| Akeso | 103.35B |
| Sino Biopharmaceutical | 90.40B |
| RemeGen | 63.94B |
| 3SBio | 45.66B |
| Shanghai Henlius Biotech | 37.23B |
| Shanghai Junshi Biosciences | 36.75B |
| Genscript Biotech | 29.06B |